Discovery of 2-Hydroxy-N, N-Dimethyl-3-{2-[[(R)-1-(5-Methylfuran-2-Yl)propyl]amino]-3, 4-Dioxocyclobut-1-Enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

doi 10.1021/jm0609622.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)


Related search